Omnicell, Inc. (OMCL): Price and Financial Metrics

Omnicell, Inc. (OMCL): $136.42

-1.45 (-1.05%)

POWR Rating

Component Grades













OMCL Stock Summary

  • OMCL's current price/earnings ratio is 184.32, which is higher than 94.83% of US stocks with positive earnings.
  • The price/operating cash flow metric for OMNICELL Inc is higher than 83.73% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 412.67%, OMNICELL Inc's debt growth rate surpasses 96.54% of about US stocks.
  • Stocks that are quantitatively similar to OMCL, based on their financial statements, market capitalization, and price volatility, are SPSC, KTOS, TECH, RGEN, and CARG.
  • Visit OMCL's SEC page to see the company's official filings. To visit the company's web site, go to

OMCL Stock Price Chart Interactive Chart >

Price chart for OMCL

OMCL Price/Volume Stats

Current price $136.42 52-week high $146.00
Prev. close $137.87 52-week low $56.16
Day low $136.38 Volume 181,300
Day high $139.38 Avg. volume 403,327
50-day MA $133.02 Dividend yield N/A
200-day MA $100.78 Market Cap 5.89B

Omnicell, Inc. (OMCL) Company Bio

Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.

OMCL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$136.42$75.28 -45%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for OMNICELL Inc. To summarize, we found that OMNICELL Inc ranked in the 40th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 45%. In terms of the factors that were most noteworthy in this DCF analysis for OMCL, they are:

  • The compound growth rate in the free cash flow of OMNICELL Inc over the past 5.56 years is 0.3%; that's better than 64.5% of cash flow producing equities in the Technology sector, where it is classified.
  • The business' balance sheet suggests that 8% of the company's capital is sourced from debt; this is greater than only 24.57% of the free cash flow producing stocks we're observing.
  • OMNICELL Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OMCL, try MSI, TDY, BKTI, CSCO, and FORM.

OMCL Latest News Stream

Event/Time News Detail
Loading, please wait...

OMCL Latest Social Stream

Loading social stream, please wait...

View Full OMCL Social Stream

Latest OMCL News From Around the Web

Below are the latest news stories about OMNICELL Inc that investors may wish to consider to help them evaluate OMCL as an investment opportunity.

Why Omnicell's CEO Puts Progress Over Politics

Putting progress ahead of politics is just one lesson Omnicell CEO Lipps picked up while building the leader in a key corner of the health care business.

Yahoo | April 15, 2021

Here's Why You Should Hold on to Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL) owing to its progress with its three-legged strategic, which is driving growth and an impressive 2025 roadmap.

Yahoo | April 12, 2021

Omnicell's (OMCL) Automated Dispensing Service Adopted by Aultman

Omnicell's (OMCL) Autonomous Pharmacy vision receives another boost with the latest service adoption by Aultman.

Yahoo | April 8, 2021

Aultman Health Foundation to Enhance Medication Management with Omnicell’s Central Pharmacy Dispensing Service

Aultman Health Foundation to Enhance Medication Management with Omnicell’s Central Pharmacy Dispensing Service

Yahoo | April 7, 2021

Has Omnicell, Inc.'s (NASDAQ:OMCL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Most readers would already be aware that Omnicell's (NASDAQ:OMCL) stock increased significantly by 20% over the past...

Yahoo | March 29, 2021

Read More 'OMCL' Stories Here

OMCL Price Returns

1-mo -1.77%
3-mo 13.29%
6-mo 61.50%
1-year 95.95%
3-year 215.06%
5-year 366.23%
YTD 13.66%
2020 46.87%
2019 33.44%
2018 26.27%
2017 43.07%
2016 9.07%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1345 seconds.